Skip to main content
. 2023 Dec 5;53(1):10. doi: 10.3892/ijmm.2023.5334

Figure 7.

Figure 7

Schematic diagram of the inhibitory effect of MT RANKL on RANK-RANKL signaling during osteoclastogenesis. GSK-3β, glycogen synthase kinase-3β; LGR4, leucine-rich repeat-containing G-protein-coupled receptor 4; MT, mutant; NFATc1, nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 1; RANK, receptor-activated nuclear factor-κB; RANKL, RANK ligand; WT, wild-type.